Integrative temporal multi-omics reveals uncoupling of transcriptome and proteome during human T cell activation
Harshi Weerakoon(The University of Queensland), Ailin Lepletier(Griffith University), Pamela Mukhopadhyay(QIMR Berghofer Medical Research Institute), Oscar Haigh(QIMR Berghofer Medical Research Institute), Ahmed Mohamed(QIMR Berghofer Medical Research Institute), Yide Wong(Australian Institute of Tropical Health and Medicine), Michelle M. Hill(The University of Queensland), Thomas S. Watkins(QIMR Berghofer Medical Research Institute), Stephen H. Kazakoff(QIMR Berghofer Medical Research Institute), Bhagya Senadheera(University of Colombo), Jinjin Chen(The University of Melbourne), John J. Miles(University of Cambridge), Jason Mulvenna(QIMR Berghofer Medical Research Institute)
Cited by 19
Related Papers
Estimating the global burden of Epstein–Barr virus-related cancers
|Journal of Cancer Research and Clinical Oncology|2021|296
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272
CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells
|Immunity|2020|181
Hormonal control of T-cell development in health and disease
|Nature Reviews Endocrinology|2015|119
CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function
|Cancer Immunology Research|2019|117